Kun Yao

445 total citations
20 papers, 361 citations indexed

About

Kun Yao is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Kun Yao has authored 20 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Kun Yao's work include Cell death mechanisms and regulation (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Synthesis and bioactivity of alkaloids (2 papers). Kun Yao is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Synthesis and bioactivity of alkaloids (2 papers). Kun Yao collaborates with scholars based in China and United States. Kun Yao's co-authors include Huihan Wang, Zhuogang Liu, Ming Zhao, Shiqi Peng, Xiaoyi Zhang, Yuji Wang, Meiqing Zheng, Yingchun Li, Ying Sun and Qinghua Cui and has published in prestigious journals such as Chemical Engineering Journal, World Journal of Gastroenterology and European Journal of Medicinal Chemistry.

In The Last Decade

Kun Yao

20 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Yao China 10 242 91 51 49 30 20 361
Hanumantha Rao Madala United States 12 201 0.8× 84 0.9× 75 1.5× 50 1.0× 26 0.9× 19 403
Yuxin Zhuang China 12 182 0.8× 81 0.9× 55 1.1× 40 0.8× 10 0.3× 26 393
Laura Caboni Ireland 9 289 1.2× 81 0.9× 74 1.5× 76 1.6× 23 0.8× 11 441
Maike Zimmermann United States 12 347 1.4× 101 1.1× 104 2.0× 29 0.6× 30 1.0× 20 522
Tiantao Gao China 12 297 1.2× 48 0.5× 96 1.9× 55 1.1× 8 0.3× 18 460
Vito Coviello Italy 11 177 0.7× 97 1.1× 85 1.7× 78 1.6× 14 0.5× 15 370
Kathrin Böpple Germany 8 226 0.9× 75 0.8× 99 1.9× 29 0.6× 9 0.3× 10 408
Sachio Shibata Japan 10 229 0.9× 35 0.4× 41 0.8× 54 1.1× 14 0.5× 14 312
Andrea L. Merz United States 11 195 0.8× 62 0.7× 115 2.3× 19 0.4× 9 0.3× 14 381
Naima Hammoudi United States 10 336 1.4× 196 2.2× 115 2.3× 25 0.5× 13 0.4× 19 560

Countries citing papers authored by Kun Yao

Since Specialization
Citations

This map shows the geographic impact of Kun Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Yao more than expected).

Fields of papers citing papers by Kun Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Yao. The network helps show where Kun Yao may publish in the future.

Co-authorship network of co-authors of Kun Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Yao. A scholar is included among the top collaborators of Kun Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Yao. Kun Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hua, et al.. (2025). Real-World safety profile of Fenfluramine in refractory epilepsy: a pharmacovigilance study based on FAERS database. Epilepsy & Behavior. 171. 110581–110581. 2 indexed citations
2.
Zhu, Yongxia, Peng Luo, Nan Huang, et al.. (2025). Design, synthesis, and biological evaluation of novel PI3Kδ/HDAC6 dual inhibitors for the treatment of non-Hodgkin's lymphoma. European Journal of Medicinal Chemistry. 296. 117852–117852. 1 indexed citations
3.
Liu, Hua, et al.. (2025). Characteristics of Adverse Events and Clinical Risks of Omaveloxolone Based on FAERS Data. The Cerebellum. 24(4). 119–119. 1 indexed citations
4.
Wang, Kai, Rui Guo, Xiulin Li, et al.. (2023). A novel fluorescent probe for imaging endogenous hydrogen sulfide in living cells and mice models of acute liver injury. Chemical Engineering Journal. 468. 143611–143611. 34 indexed citations
5.
Yao, Kun, et al.. (2023). Exploring the oral‐gut microbiota during thyroid cancer: Factors affecting the thyroid functions and cancer development. Food Science & Nutrition. 11(10). 5657–5674. 7 indexed citations
6.
Jing, Feng, Kun Yao, Qiuping Gui, et al.. (2023). Primary papillary epithelial tumor of the sella and posterior pituitary tumor show similar (epi)genetic features and constitute a single neuro-oncological entity. Neuro-Oncology. 25(8). 1487–1497. 7 indexed citations
7.
Yao, Kun, Xufeng Fu, Xing Du, et al.. (2018). PGC-1α coordinates with Bcl-2 to control the cell cycle in U251 cells through reducing ROS. Journal of Zhejiang University SCIENCE B. 19(6). 415–424. 4 indexed citations
8.
Du, Xing, Xufeng Fu, Kun Yao, et al.. (2017). Bcl-2 delays cell cycle through mitochondrial ATP and ROS. Cell Cycle. 16(7). 707–713. 34 indexed citations
9.
Wei, Ran, Qin Yang, Bing Han, et al.. (2017). microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways. Oncotarget. 8(10). 16633–16641. 48 indexed citations
10.
Liu, Hui, Huihan Wang, Bin Wu, et al.. (2017). Down‐regulation of long non‐coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma. Clinical and Experimental Pharmacology and Physiology. 44(10). 1032–1041. 23 indexed citations
11.
Li, Jianlong, Jinquan Cai, Shihong Zhao, et al.. (2016). GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment. Journal of Experimental & Clinical Cancer Research. 35(1). 184–184. 59 indexed citations
12.
Zhou, Xin, Kun Yao, Lang Zhang, et al.. (2016). Identification of Differentiation-Related Proteins in Gastric Adenocarcinoma Tissues by Proteomics. Technology in Cancer Research & Treatment. 15(5). 697–706. 9 indexed citations
13.
Yao, Kun, et al.. (2015). Effect of TIEG1 on apoptosis and expression of Bcl-2/Bax and Pten in leukemic cell lines. Genetics and Molecular Research. 14(1). 1968–1974. 15 indexed citations
14.
Yang, Ying, Rong Hu, Ke Zhu, et al.. (2015). [Involvement of oxidative stress in embelin-induced cell death in leukemia HL-60 cells].. PubMed. 36(6). 465–8. 3 indexed citations
16.
Li, Yingchun, Zhuogang Liu, Kun Yao, et al.. (2013). [Mechanisms of ROS in U266 cell death induced by FTY720].. PubMed. 21(3). 643–6. 4 indexed citations
18.
Liao, Aijun, Rong Hu, Yingchun Li, et al.. (2011). [The study of FTY720 on inducing apoptosis and autophagy in multiple myeloma cell line U266].. PubMed. 32(10). 664–7. 6 indexed citations
19.
Hu, Rong, Ke Zhu, Yingchun Li, et al.. (2010). Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells. Medical Oncology. 28(4). 1584–1588. 39 indexed citations
20.
Shen, Lizong, WU Wen-xi, Dehua Xu, et al.. (2002). Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene. World Journal of Gastroenterology. 8(2). 270–270. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026